Pfizer names 6 general managers for new business units

Recently, Pfizer has successively announced the general managers and heads of other divisions of its six independent divisions except rare diseases and broad markets
.

General Manager of Oncology Division: Wang Yiqin

General Manager of Oncology Division: Wang Yiqin

Yiqin Wang was previously the Vice President of Marketing.
She joined Pfizer in 2020 and has accumulated extensive sales and marketing expertise in different therapeutic areas and multiple Asia-Pacific markets
.

General Manager of Hospital Emergency Department: Li Jinhui

General Manager of Hospital Emergency Department: Li Jinhui

Previously, Li Jinhui was the general manager of Pfizer China's oncology and rare disease business.
He has worked at Pfizer for more than 23 years and has been responsible for product lines in many major disease areas, such as anti-infection, cardiovascular, pain, oncology and rare diseases.
Sales management work
.

General Manager of Vaccine Division: Zhang Lingyan

General Manager of Vaccine Division: Zhang Lingyan

Lingyan Zhang has over 23 years of experience in the medical and pharmaceutical industries
.

Before joining Pfizer, she worked at Merck for 8 years as the national senior director of the vaccine business unit, responsible for the sales, regional government affairs, access and other work of the vaccine business unit

Previously, she worked at AstraZeneca for more than 7 years, responsible for the sales and market management of products in various fields such as oncology, central nervous system, emergency, digestion, and surgery
.

Zhang Lingyan was originally a pediatric surgeon at West China Hospital, and later, she also worked in sales and marketing for Serono and GlaxoSmithKline

General Manager of Inflammation and Immunity Division: Dai Wenjie

General Manager of Inflammation and Immunity Division: Dai Wenjie

Dai Wenjie's appointment just took effect on January 6, 2022
.

He has over 20 years of experience in the Chinese pharmaceutical industry and has held a range of positions including National Sales Director, Marketing Director and Marketing Manager

Head of Market Access: Qian Yun

Head of Market Access: Qian Yun

Qian Yun, who was originally the head of market access at Pfizer, is now appointed as the head of market access, including the key account team
.

She joined Pfizer in 2020 with over 20 years of experience in market access and public affairs in the pharmaceutical industry

Head of Hospital Access and Strategic Cooperation: Niu Yanlai

Head of Hospital Access and Strategic Cooperation: Niu Yanlai

Niu Yanlai has 19 years of experience in the pharmaceutical industry.
He has worked in domestic R&D companies, Pfizer, and Bayer, and has been engaged in registration, sales, and regional markets
.

She has held various management positions at PBG, including Head of the Inflammation and Immunity Marketing Department, and Head of the General Medicines Market

Source: Siqi Club